VYNE Therapeutics Inc.
VYNENASDAQHealthcareBiotechnology
As of Jul 27, 2026 close
- Market cap
- $1.22B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- 70.45%
- 52-week range
- $0.32$46.95
- Volume (live)
- -
- Avg. volume (3M)
- 93.25K
VYNE Therapeutics (VYNE) Stock Price & Financial Analysis
VYNE Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $23.37 - $28.56 |
|---|---|
| 52-Week High | $46.95 |
| 52-Week Low | $0.32 |
| Open | $25.50 |
| Volume (last close) | 93.25K |
| Average Volume (3M) | 93.25K |
| Revenue (TTM) | 454.00K |
|---|---|
| Net Income (TTM) | -21.46M |
| Free Cash Flow (TTM) | -25.74M |
| EPS (TTM) | −$0.66 |
| Profit Margin | -4726.21% |
| Operating Margin | -7044.05% |
| Return on Equity (ROE) | -87.09% |
| Debt to Equity | 0.00 |
| Annual Dividend | $20.12 |
|---|---|
| Dividend Yield | 70.45% |
| Last Dividend Ex-Date | Jul 24, 2026 |
| Market Cap | 1.22B |
|---|---|
| Shares Outstanding | 42.77M |
| Price to Sales (P/S) | 2690.43 |
| Price to Book (P/B) | 49.58 |
| EV/EBITDA | -50.18 |
| 50-Day MA | $34.07 |
|---|---|
| 200-Day MA | $10.84 |
| 1-Year Change | +7621.01% |
Source: Market prices and company fundamentals. Data as of Jul 27, 2026. Data sources and methodology
VYNE Therapeutics at a Glance
As of the Jul 27, 2026 close, VYNE Therapeutics (VYNE) has a market capitalization of $1.22B. The stock trades at 2690.4× sales. Over the trailing twelve months it lost $21.46M on revenue of $454.00K and burned $25.74M of free cash flow. Revenue fell 25.0% year over year.
As of its latest reported balance sheet, it holds $24.63M in cash and securities against $0.00 of debt, a net cash position of $24.63M.
VYNE Therapeutics pays dividends totaling $20.12 per share a year, a 70.45% yield at the Jul 27, 2026 close.
The share price is up 7621.0% over the past year. At $28.56 (the Jul 27, 2026 close) it sits within its 52-week range of $0.32 to $46.95, above its 200-day moving average of $10.84.
Frequently Asked Questions About VYNE Therapeutics
What is the current stock price for VYNE?
As of the Jul 27, 2026 close, VYNE stock trades at $28.56. The 52-week range is $0.32–$46.95, with a day range of $23.37–$28.56.
What is the P/E ratio for VYNE?
The P/E ratio (Price-to-Earnings) for VYNE is shown in the Key Statistics section. This valuation metric helps compare VYNE Therapeutics Inc. to industry peers.
Does VYNE pay dividends?
Yes, VYNE Therapeutics pays a 70.45% annual dividend yield as of the Jul 27, 2026 close ($20.12 per share a year). The most recent ex-dividend date was July 24, 2026.
What do analysts recommend for VYNE?
Analyst ratings and recommendations for VYNE are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of VYNE?
As of the Jul 27, 2026 close, VYNE Therapeutics's market capitalization is $1.22B, classifying it as a small-cap company. VYNE Therapeutics operates in the Healthcare sector within the Biotechnology industry.